A distance-learning course on hypertrophic cardiomyopathy (HCM) is now available on Heart Rhythm 365 for free. HCM is an underrecognized disease that if untreated, carries an increased risk for arrhythmias, including atrial fibrillation (AF), as well as stroke, and in some instances, sudden cardiac death.
The 50-minute accredited course was released earlier this week by the Heart Rhythm Society. The program provides the latest evidence in the treatment and management of HCM symptoms. In part one of the series, Daniel Jacoby, MD, director of comprehensive heart failure and cardiomyopathy program, discusses recent findings from observational clinical trials in, “Exploring the Latest Evidence of Treatment of HCM. What’s on the Horizon.”
The webinar is appropriate for health care professionals who are interested in the management of heart rhythm disorders.
To learn about Yale’s a comprehensive diagnostic, treatment, education, and research for hypertrophic, dilated, arrhythmogenic, and restrictive cardiomyopathies, visit our website.